
Strategic Transactions Advocacy Track (STAT)
August 6, 2026
STAT delivers U.S. Government Advocacy for Foreign Investment & Concession Projects — turbocharging efforts to help U.S. companies outcompete state-backed rivals on strategic deals.
Who is Eligible?
Firms incorporated in the United States or with substantial U.S. ownership competing for foreign concession and investment opportunities involving a foreign government decision-maker and foreign competitors, including those with roles in public-private partnerships.
How do U.S. Firms Participate?
Interested U.S. firms submit a confidential application containing project details, including the timeline, competitors, and foreign decision-makers. The application review timeframe is typically within two weeks.
There is no fee to participate in the STAT program.
For more information on this program, please contact Daniel.Bruner@trade.gov.
Recent News
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
- Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology














